XML 30 R19.htm IDEA: XBRL DOCUMENT v3.7.0.1
Segment Information
3 Months Ended
Mar. 31, 2017
Segment Reporting [Abstract]  
Reportable Segments
Segment Information:

Our three reportable segments include Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Each segment has a dedicated team of sales, research and development, process engineering, manufacturing and sourcing, and business strategy personnel and has full accountability for improving execution through greater asset and market focus, agility and responsiveness. This structure aligns with the markets and customers we serve through each of the segments. The structure also facilitates the continued standardization of business processes across the organization, and is consistent with the manner in which information is presently used internally by the Company’s chief operating decision maker to evaluate performance and make resource allocation decisions.
Summarized financial information concerning our reportable segments is shown in the following tables.
The “All Other” category comprises operating segments that did not fit into any of our core businesses. During the first quarter of 2016, we completed the sales of the metal sulfides business and the minerals-based flame retardants and specialty chemicals businesses. For additional information about these businesses, see Note 3, “Divestitures.” Following the sales of these businesses, the “All Other” category includes only the fine chemistry services business.
The Corporate category is not considered to be a segment and includes corporate-related items not allocated to the operating segments. Pension and OPEB service cost (which represents the benefits earned by active employees during the period) and amortization of prior service cost or benefit are allocated to the reportable segments, All Other, and Corporate, whereas the remaining components of pension and OPEB benefits cost or credit (“Non-operating pension and OPEB items”) are included in Corporate. Segment data includes intersegment transfers of raw materials at cost and allocations for certain corporate costs.
The Company’s chief operating decision maker uses earnings before interest, taxes, depreciation and amortization, as adjusted on a consistent basis for certain non-recurring or unusual items such as acquisition and integration related costs, utilization of inventory markup, gains or losses on sales of businesses, restructuring charges, facility divestiture charges, non-operating pension and OPEB items and other significant non-recurring items (“adjusted EBITDA”), in a balanced manner and on a segment basis to assess the ongoing performance of the Company’s business segments and to allocate resources. In addition, management uses adjusted EBITDA for business planning purposes and as a significant component in the calculation of performance-based compensation for management and other employees. The Company has reported adjusted EBITDA because management believes it provides transparency to investors and enables period-to-period comparability of financial performance. Adjusted EBITDA is a financial measure that is not required by, or presented in accordance with, U.S. GAAP. Adjusted EBITDA should not be considered as an alternative to Net income (loss) attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with U.S. GAAP, or any other financial measure reported in accordance with U.S. GAAP.
 
Three Months Ended 
 March 31,
 
2017
 
2016
 
(In thousands)
Net sales:
 
 
 
Lithium and Advanced Materials
$
284,375

 
$
216,173

Bromine Specialties
219,191

 
196,553

Refining Solutions
185,412

 
170,579

All Other
32,419

 
72,089

Corporate
666

 
1,817

Total net sales
$
722,063

 
$
657,211

 
 
 
 
Adjusted EBITDA:
 
 
 
Lithium and Advanced Materials
$
120,022

 
$
86,474

Bromine Specialties
68,488

 
61,608

Refining Solutions
49,579

 
55,074

All Other
5,156

 
8,464

Corporate
(31,869
)
 
(19,587
)
Total adjusted EBITDA
$
211,376

 
$
192,033


See below for a reconciliation of adjusted EBITDA, the non-GAAP financial measure, from Net income (loss) attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with U.S. GAAP (in thousands):
 
Lithium and Advanced Materials
 
Bromine Specialties
 
Refining Solutions
 
Reportable Segments Total
 
All Other
 
Corporate
 
Consolidated Total
Three months ended March 31, 2017
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss) attributable to Albemarle Corporation
$
94,106

 
$
58,694

 
$
40,474

 
$
193,274

 
$
3,246

 
$
(145,307
)
 
$
51,213

Depreciation and amortization
22,743

 
9,794

 
9,105

 
41,642

 
1,910

 
1,518

 
45,070

Utilization of inventory markup(a)
10,606

 

 

 
10,606

 

 

 
10,606

Restructuring and other(b)

 

 

 

 

 
12,905

 
12,905

Gain on acquisition(c)
(7,433
)
 

 

 
(7,433
)
 

 

 
(7,433
)
Acquisition and integration related costs(d)

 

 

 

 

 
14,281

 
14,281

Interest and financing expenses(e)

 

 

 

 

 
68,513

 
68,513

Income tax expense

 

 

 

 

 
11,971

 
11,971

Non-operating pension and OPEB items

 

 

 

 

 
(1,063
)
 
(1,063
)
Other(f)

 

 

 

 

 
5,313

 
5,313

Adjusted EBITDA
$
120,022

 
$
68,488

 
$
49,579

 
$
238,089

 
$
5,156

 
$
(31,869
)
 
$
211,376

Three months ended March 31, 2016
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss) attributable to Albemarle Corporation
$
63,327

 
$
51,853

 
$
46,314

 
$
161,494

 
$
130,709

 
$
(64,017
)
 
$
228,186

Depreciation and amortization
23,147

 
9,755

 
8,760

 
41,662

 
612

 
1,335

 
43,609

(Gain) loss on sales of businesses, net(g)

 

 

 

 
(122,857
)
 
1,533

 
(121,324
)
Acquisition and integration related costs(d)

 

 

 

 

 
18,558

 
18,558

Interest and financing expenses

 

 

 

 

 
15,114

 
15,114

Income tax expense

 

 

 

 

 
25,485

 
25,485

Income from discontinued operations (net of tax)

 

 

 

 

 
(17,312
)
 
(17,312
)
Non-operating pension and OPEB items

 

 

 

 

 
(283
)
 
(283
)
Adjusted EBITDA
$
86,474

 
$
61,608

 
$
55,074

 
$
203,156

 
$
8,464

 
$
(19,587
)
 
$
192,033


(a)
In connection with the acquisition of Jiangli New Materials, the Company valued inventory purchased from Jiangli New Materials at fair value, which resulted in a markup of the underlying net book value of the inventory totaling approximately $23.0 million. The inventory markup is being expensed over the estimated remaining selling period. For the three-month period ended March 31, 2017, $10.6 million was included in Cost of goods sold related to the utilization of the inventory markup.
(b)
During the first quarter of 2017, we initiated action to reduce costs at several locations, primarily at our Lithium site in Germany. Based on the restructuring plans, we have recorded expenses of $2.9 million in Cost of goods sold, $4.2 million in Selling, general and administrative expenses and $5.8 million in Research and development expenses, primarily related to severance, expected to be incurred. The unpaid balance is recorded in Accrued expenses at March 31, 2017, with the expectation that the majority of this plan will be completed by the end of 2017.
(c)
Gain recorded in Other (expenses) income, net related to the acquisition of the remaining 50% interest in Salmag. See Note 2, “Acquisitions,” for additional information.
(d)
See Note 2, “Acquisitions,” for additional information.
(e)
Included in Interest and financing expenses is a loss on early extinguishment of debt of $52.8 million. See Note 10, “Long-term Debt,” for additional information.
(f)
Included in Other (expenses) income, net are $3.2 million of asset retirement obligation charges related to the revision of an estimate at a site formerly owned by Albemarle and a loss of $2.1 million associated with the previous disposal of a business.
(g)
See Note 3, “Divestitures,” for additional information.